The New Regulation (EU) 2017/745 for medical devices (MDRs), which went into effect on May 26, 2021, is a major update to the regulatory framework in the European Union (EU).
Today’s disruptive market scenarios, the unknown consequences of COVID-19, increasingly sophisticated personalized, and the new FDA and EU Regulatory implications…
The COVID-19 pandemic has disrupted global supply chains on a monumental scale, rushing all MD&D manufacturers to quickly re-adapt and respond to new challenging market scenarios.
Terumo Americas is a global leader in medical device industry manufacturing life-supporting and sustaining Class III devices across four divisions over the last 50 years, including interventional systems, injection and infusion therapy devices and drug delivery devices.
